African Union seeks to boost vaccine-making with 5 new centres

Bloc aims to produce 60 percent of all vaccines used on the continent in 20 years, compared with one percent today.

The African Union (AU) has announced the launch of a partnership to manufacture vaccines at five research centres to be built on the continent within the next 15 years. The Coalition for Epidemic Preparedness Innovations (CEPI), which helps run the global COVAX coronavirus vaccine-sharing programme with the public-private alliance Gavi and the World Health Organization (WHO), signed a memorandum of understanding to boost African vaccine research and development as well as manufacturing. The five centres will be located in the north, south, east, west and centre of Africa over the next 10-15 years, according to John Nkengasong, director of the Africa Centres for Disease Control and Prevention (CDC), an AU agency.